Aptar Pharma and Massachusetts General Hospital Partner to Advance Nose-to-Brain Drug Delivery

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, announced that it has...

September 16, 2026 | Wednesday | News
Elixir Medical Secures Japan Approval for DynamX Sirolimus-Eluting Coronary Bioadaptor System

Elixir Medical (Milpitas, Calif., and Tokyo) announced that its DynamX® Sirolimus-Eluting Coronary Bioadaptor System for the treatment of cor...

September 16, 2026 | Wednesday | News
Icosagen Develops High-Titer CHO Cell Line for EPOK’s Engineered Therapeutic Protein

Icosagen's IcoCell® platform delivered a high-titer, stable CHO cell line for a precision engineered therapeutic antibody-like protein, providing the f...

September 16, 2026 | Wednesday | News
Sygnature Discovery Formalises X-Chem Collaboration to Expand DNA-Encoded Library Screening

Sygnature Discovery, a leading integrated drug discovery contract research organisation (CRO), has established a formal collaboration with X-Chem, a data...

September 16, 2026 | Wednesday | News
Basilea Partner Asahi Kasei Starts Phase 2 Cresemba Study in Children in Japan

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bac...

September 15, 2026 | Tuesday | News
Cellectis Shifts Focus to In Vivo Gene Editing With HEAL-101 and HEAL-201

Cellectis to advance two lead in vivo programs .HEAL-101 and .HEAL-201 in severe dyslipidemias with preliminary Phase 1 data planned in H2 2027 and H1 ...

September 15, 2026 | Tuesday | News
Novo Nordisk Rebrands as Novo With New ‘Lasting Health Starts Now’ Identity

Novo Nordisk marked the beginning of its next chapter today by unveiling a rebrand centred on ‘Lasting Health Starts Now’, and the single &ls...

September 15, 2026 | Tuesday | News
XORTX Begins GMP Drug Substance and Tablet Manufacturing for XORLO™

Contract manufacturing of GMP drug substance and commercial-scale tablets to support the XRX-OXY-102 clinical study and future US FDA marketing approval...

September 14, 2026 | Monday | News
NRx Pharmaceuticals Deploys FDA-Cleared Robotic TMS System at HOPE Clinics

HOPE is the first Interventional Psychiatry network to deploy Zeta Surgical's newly FDA-cleared TMS Robotic System; the HOPE clinical team is completin...

September 14, 2026 | Monday | News
Roche and MediLink Report Positive Phase III Tam-Peli Data in Relapsed Small-Cell Lung Cancer

Tambotatug pelitecan (Tam-Peli) demonstrated statistically significant efficacy over topotecan in a phase III study conducted in China, reducing the ri...

September 14, 2026 | Monday | News
Lonza Expands US Spray-Drying Capacity with New Commercial Facility in Oregon

  Lonza will build a new large-scale, commercial PSD-4 spray-drying facility in Bend, Oregon (US) to support a rapidly expanding market segment ...

September 11, 2026 | Friday | News
Robinson Pharma Expands Southern California Footprint with $115M+ Facility Investment

Leading nutraceutical contract manufacturer secures prime Irvine facility near John Wayne Airport, marking its tenth operational site and further elevati...

September 11, 2026 | Friday | News
Seismic Pharmaceuticals Enrols First Patient in Global Phase III Istaroxime Trial for Cardiogenic Shock

Approximately 600 patients expected to be enrolled at clinical sites across the United States, Europe, China and South America Global Phase 3 program, R...

September 11, 2026 | Friday | News
Insilico Medicine Doses First Patient in Phase III Trial of AI-Discovered Rentosertib for IPF

Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, announced that it has dosed the first patien...

September 11, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close